OICS v0.3.3 class · Healthcare

Generics & Consumer Health

ID GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest.

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector: HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group: HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry: HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies1,256 Listed with filings866

Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company	Ticker	Country	Market cap	Filings
GenMont Biotech Inc.	3164	Taiwan	$43.90M	2,007
Sfd Spolka Akcyjna	SFD	Poland	$47.49M	790
Yuyu Pharma, Inc.	000220	South Korea	$41.55M	1,671
Rekah Pharmaceutical Prod Ltd.	REKA	Israel	$40.37M	1,856
MYUNGMOON PHARM CO.,LTD	017180	South Korea	$27.42M	1,040
Labiana S.A.	LAB	Spain	$64.83M	309
SKINBIOTHERAPEUTICS PLC	SBTX	United Kingdom	$35.44M	323
Aprogen Biologics Inc.	003060	South Korea	$17.37M	1,650
UNITED GUARDIAN INC	UG	United States of America	$30.46M	490
Valbiotis	ALVAL	France	$27.65M	484
AYTU BIOPHARMA, INC	AYTU	United States of America	$23.51M	952
TherapeuticsMD, Inc.	TXMD	United States of America	$23.15M	1,185
SynCore Biotechnology Co.,Ltd	4192	Taiwan	$22.17M	1,392
NATURAL ALTERNATIVES INTERNATIONAL INC	NAII	United States of America	$15.94M	776
DONGSUNG PHARMACEUTICAL CO.,LTD	002210	South Korea	$15.80M	1,071
Xbrane Biopharma	XBRANE	Sweden	$23.59M	448
Lipocine Inc.	LPCN	United States of America	$19.62M	830
Biogena Group Invest AG	BIO	Austria	$14.77M	11
New Nordic Healthbrands AB	NNH	Sweden	$9.35M	312
Scienture Holdings, Inc.	SCNX	United States of America	$11.58M	510
Synergy CHC Corp.	SNYR	United States of America	$11.48M	256
MANNATECH INC	MTEX	United States of America	$11.01M	1,168
Caring Brands, Inc.	CABR	United States of America	$10.41M	57
Pharmena S.A.	PHR	Poland	$9.37M	1,443
Arctic Bioscience	ABS	Norway	$9.30M	468
FUTURA MEDICAL PLC	FUM	United Kingdom	$4.81M	675
Wellnex Life Limited	WNX	Australia	$7.93M	775
Immuron Ltd	IMRN	Australia	$8.82M	1,657
Gelteq Ltd	GELS	United States of America	$7.27M	72
OPTIBIOTIX HEALTH PLC	OPTI	United Kingdom	$8.82M	481
NUTEX Investments Plc	NUTEX	Hungary	$5.13M	81
Dermata Therapeutics, Inc.	DRMA	United States of America	$5.39M	364
Sonoma Pharmaceuticals, Inc.	SNOA	United States of America	$6.03M	972
CHINA PHARMA HOLDINGS, INC.	CPHI	United States of America	$24.91M	425
Agape ATP Corp	ATPC	United States of America	$2.52M	167
Enorama Pharma AB	ERMA	Sweden	$2.71M	346
China SXT Pharmaceuticals, Inc.	SXTC	Virgin Islands (British)	$1.41M	167
Universe Pharmaceuticals INC	UPC	United States of America	$2.19M	118
Functional Brands Inc.	MEHA	United States of America	$219k	58
NAVCO Pharmaceuticals	NAV	Canada	$208k	206
Lupin Ltd	LUPIN	India	—	8,524
Aurobindo Pharma Ltd.	AUROPHARMA	India	—	5,182
Zydus Lifesciences Limited	ZYDUSLIFE	India	—	4,914
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	India	—	4,694
Biocon Ltd.	BIOCON	India	—	4,431
STRIDES PHARMA SCIENCE LIMITED	STAR	India	—	4,227
Cipla Ltd.	CIPLA	India	—	4,164
Krka	KRKG	Slovenia	—	3,648
Glenmark Pharmaceuticals ltd	GLENMARK	India	—	3,615
Shandong Xinhua Pharmaceutical Company Limited	719	China	—	3,448

Companies in Pharmaceuticals → Open in the screener →

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

genericsOTCAPI manufacturerbiosimilars

Not here

makes ingredients or drugs under contract for other drug companies → CRO Contract Research & Manufacturing
mostly its own patented medicines → RXB Branded Prescription Drugs or CMB Commercial Biotech

Sent here from

Other classes in Pharmaceuticals

Branded Prescription Drugs RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Also big pharma, innovative pharmaceuticals, animal health

Not here no approved product → CLB Clinical-Stage Biotech
Not here approved products in one or two therapeutic areas, research-led → CMB Commercial Biotech
Not here mostly generics, off-patent brands and over-the-counter products → GNX Generics & Consumer Health

Permanent link

https://financialfilings.com/oics/GNX/

This page is keyed by the class ID GNX. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard